Annual Non Current Assets
$549.79 M
+$50.72 M+10.16%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual long term assets is currently $549.79 million, with the most recent change of +$50.72 million (+10.16%) on 31 December 2023. During the last 3 years, it has fallen by -$311.94 million (-36.20%). LGND annual non current assets is now -36.20% below its all-time high of $861.73 million, reached on 31 December 2020.LGND Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$645.48 M
+$91.33 M+16.48%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly long term assets is currently $645.48 million, with the most recent change of +$91.33 million (+16.48%) on 30 September 2024. Over the past year, it has increased by +$130.25 million (+25.28%). LGND quarterly non current assets is now -25.09% below its all-time high of $861.73 million, reached on 31 December 2020.LGND Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.2% | +25.3% |
| 3 y3 years | -36.2% | -23.3% |
| 5 y5 years | +40.9% | +77.2% |
LGND Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.2% | +10.2% | -23.3% | +34.1% |
| 5 y | 5 years | -36.2% | +48.1% | -25.1% | +81.7% |
| alltime | all time | -36.2% | >+9999.0% | -25.1% | >+9999.0% |
Ligand Pharmaceuticals Incorporated Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $645.48 M(+16.5%) |
| June 2024 | - | $554.15 M(+1.7%) |
| Mar 2024 | - | $544.96 M(-0.9%) |
| Dec 2023 | $237.43 M(-9.9%) | $549.79 M(+6.7%) |
| Sept 2023 | - | $515.23 M(+7.0%) |
| June 2023 | - | $481.39 M(-0.3%) |
| Mar 2023 | - | $482.88 M(-3.2%) |
| Dec 2022 | $263.60 M(-43.3%) | $499.07 M(-39.9%) |
| Sept 2022 | - | $830.17 M(-0.3%) |
| June 2022 | - | $832.50 M(+0.4%) |
| Mar 2022 | - | $829.12 M(-0.4%) |
| Dec 2021 | $464.75 M(-7.2%) | $832.84 M(-1.0%) |
| Sept 2021 | - | $841.57 M(-0.5%) |
| June 2021 | - | $845.38 M(-1.4%) |
| Mar 2021 | - | $857.69 M(-0.5%) |
| Dec 2020 | $500.56 M(-55.5%) | $861.73 M(+121.1%) |
| Sept 2020 | - | $389.71 M(+2.7%) |
| June 2020 | - | $379.31 M(+6.8%) |
| Mar 2020 | - | $355.19 M(-4.3%) |
| Dec 2019 | $1.12 B(+29.1%) | $371.27 M(+1.9%) |
| Sept 2019 | - | $364.37 M(+1.3%) |
| June 2019 | - | $359.53 M(+3.9%) |
| Mar 2019 | - | $346.09 M(-11.3%) |
| Dec 2018 | $870.54 M(+267.3%) | $390.26 M(+8.3%) |
| Sept 2018 | - | $360.52 M(-4.6%) |
| June 2018 | - | $377.81 M(-6.9%) |
| Mar 2018 | - | $405.62 M(-6.5%) |
| Dec 2017 | $237.02 M(+45.4%) | $434.00 M(-0.9%) |
| Sept 2017 | - | $438.14 M(-1.1%) |
| June 2017 | - | $442.85 M(-2.7%) |
| Mar 2017 | - | $455.02 M(+3.8%) |
| Dec 2016 | $163.05 M(-24.1%) | $438.53 M(-4.7%) |
| Sept 2016 | - | $460.17 M(-6.1%) |
| June 2016 | - | $490.24 M(+2.1%) |
| Mar 2016 | - | $480.38 M(+66.6%) |
| Dec 2015 | $214.71 M(+16.0%) | $288.35 M(-7.4%) |
| Sept 2015 | - | $311.38 M(+188.2%) |
| June 2015 | - | $108.04 M(+51.1%) |
| Mar 2015 | - | $71.51 M(-1.9%) |
| Dec 2014 | $185.16 M(+644.2%) | $72.87 M(-1.2%) |
| Sept 2014 | - | $73.76 M(+3.5%) |
| June 2014 | - | $71.26 M(-1.1%) |
| Mar 2014 | - | $72.07 M(-9.7%) |
| Dec 2013 | $24.88 M(+4.4%) | $79.83 M(-6.1%) |
| Sept 2013 | - | $85.04 M(+0.0%) |
| June 2013 | - | $85.00 M(+5.4%) |
| Mar 2013 | - | $80.62 M(+0.2%) |
| Dec 2012 | $23.82 M(-26.1%) | $80.44 M(+0.5%) |
| Sept 2012 | - | $80.07 M(-4.1%) |
| June 2012 | - | $83.50 M(-5.4%) |
| Mar 2012 | - | $88.25 M(-0.1%) |
| Dec 2011 | $32.23 M(-12.9%) | $88.35 M(-7.6%) |
| Sept 2011 | - | $95.65 M(-3.7%) |
| June 2011 | - | $99.30 M(-3.5%) |
| Mar 2011 | - | $102.86 M(+166.9%) |
| Dec 2010 | $37.02 M(-45.7%) | $38.54 M(-50.1%) |
| Sept 2010 | - | $77.28 M(-8.2%) |
| June 2010 | - | $84.19 M(+1.2%) |
| Mar 2010 | - | $83.23 M(+13.0%) |
| Dec 2009 | $68.17 M | $73.64 M(+28.8%) |
| Sept 2009 | - | $57.19 M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $59.71 M(-17.0%) |
| Mar 2009 | - | $71.89 M(-7.3%) |
| Dec 2008 | $93.93 M(-14.6%) | $77.52 M(+26.6%) |
| Sept 2008 | - | $61.23 M(-4.2%) |
| June 2008 | - | $63.91 M(-0.7%) |
| Mar 2008 | - | $64.37 M(+1.6%) |
| Dec 2007 | $109.94 M(-53.3%) | $63.34 M(-33.9%) |
| Sept 2007 | - | $95.75 M(-0.6%) |
| June 2007 | - | $96.29 M(-0.6%) |
| Mar 2007 | - | $96.86 M(+7.0%) |
| Dec 2006 | $235.56 M(+77.2%) | $90.50 M(-45.9%) |
| Sept 2006 | - | $167.34 M(-2.7%) |
| June 2006 | - | $172.03 M(-2.4%) |
| Mar 2006 | - | $176.35 M(-2.9%) |
| Dec 2005 | $132.97 M(-21.0%) | $181.65 M(-3.6%) |
| Sept 2005 | - | $188.34 M(-2.5%) |
| June 2005 | - | $193.18 M(+6.4%) |
| Mar 2005 | - | $181.55 M(+10.5%) |
| Dec 2004 | $168.21 M(+17.8%) | $164.26 M(+0.6%) |
| Sept 2004 | - | $163.33 M(-1.9%) |
| June 2004 | - | $166.51 M(-1.6%) |
| Mar 2004 | - | $169.29 M(-1.2%) |
| Dec 2003 | $142.78 M(+61.2%) | $171.27 M(+2.6%) |
| Sept 2003 | - | $166.94 M(-1.8%) |
| June 2003 | - | $169.96 M(-4.6%) |
| Mar 2003 | - | $178.16 M(-4.7%) |
| Dec 2002 | $88.57 M(+65.3%) | $186.86 M(+167.9%) |
| Sept 2002 | - | $69.76 M(+5.0%) |
| June 2002 | - | $66.44 M(-1.9%) |
| Mar 2002 | - | $67.76 M(+6.0%) |
| Dec 2001 | $53.57 M(+20.0%) | $63.90 M(-1.6%) |
| Sept 2001 | - | $64.93 M(-3.3%) |
| June 2001 | - | $67.12 M(-2.2%) |
| Mar 2001 | - | $68.61 M(-0.2%) |
| Dec 2000 | $44.65 M(-21.3%) | $68.77 M(-3.1%) |
| Sept 2000 | - | $70.97 M(-3.4%) |
| June 2000 | - | $73.48 M(+3.3%) |
| Mar 2000 | - | $71.15 M(-8.7%) |
| Dec 1999 | $56.70 M(-27.3%) | $77.90 M(+1.2%) |
| Sept 1999 | - | $77.00 M(-2.7%) |
| June 1999 | - | $79.10 M(+2.7%) |
| Mar 1999 | - | $77.00 M(-1.3%) |
| Dec 1998 | $78.00 M(-7.3%) | $78.00 M(-2.1%) |
| Sept 1998 | - | $79.70 M(+165.7%) |
| June 1998 | - | $30.00 M(+16.7%) |
| Mar 1998 | - | $25.70 M(+10.3%) |
| Dec 1997 | $84.10 M(-1.5%) | $23.30 M(+0.9%) |
| Sept 1997 | - | $23.10 M(-1.3%) |
| June 1997 | - | $23.40 M(+16.4%) |
| Mar 1997 | - | $20.10 M(+20.4%) |
| Dec 1996 | $85.40 M(+17.0%) | $16.70 M(0.0%) |
| Sept 1996 | - | $16.70 M(-2.9%) |
| June 1996 | - | $17.20 M(-3.4%) |
| Mar 1996 | - | $17.80 M(-13.6%) |
| Dec 1995 | $73.00 M(+75.5%) | $20.60 M(+7.3%) |
| Sept 1995 | - | $19.20 M(+262.3%) |
| Mar 1995 | - | $5.30 M(+3.9%) |
| Dec 1994 | $41.60 M | $5.10 M(-3.8%) |
| Sept 1994 | - | $5.30 M(+12.8%) |
| June 1994 | - | $4.70 M(+2.2%) |
| Mar 1994 | - | $4.60 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual long term assets?
- What is the all time high annual non current assets for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual non current assets year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly long term assets?
- What is the all time high quarterly non current assets for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly non current assets year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual long term assets?
The current annual non current assets of LGND is $549.79 M
What is the all time high annual non current assets for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual long term assets is $861.73 M
What is Ligand Pharmaceuticals Incorporated annual non current assets year-on-year change?
Over the past year, LGND annual long term assets has changed by +$50.72 M (+10.16%)
What is Ligand Pharmaceuticals Incorporated quarterly long term assets?
The current quarterly non current assets of LGND is $645.48 M
What is the all time high quarterly non current assets for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly long term assets is $861.73 M
What is Ligand Pharmaceuticals Incorporated quarterly non current assets year-on-year change?
Over the past year, LGND quarterly long term assets has changed by +$130.25 M (+25.28%)